MUPIROCIN CALCIUM

N/A

Manufactured by NORTHSTAR RX LLC

31,213 FDA adverse event reports analyzed

Last updated: 2026-04-14

About MUPIROCIN CALCIUM

MUPIROCIN CALCIUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by NORTHSTAR RX LLC. The most commonly reported adverse reactions for MUPIROCIN CALCIUM include DRUG INEFFECTIVE, OFF LABEL USE, NAUSEA, PAIN, PRODUCT USE IN UNAPPROVED INDICATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MUPIROCIN CALCIUM.

Top Adverse Reactions

DRUG INEFFECTIVE1,502 reports
OFF LABEL USE937 reports
NAUSEA900 reports
PAIN892 reports
PRODUCT USE IN UNAPPROVED INDICATION823 reports
MACULAR DEGENERATION811 reports
FATIGUE777 reports
HEADACHE725 reports
DIARRHOEA658 reports
CHRONIC KIDNEY DISEASE582 reports
RASH569 reports
WEIGHT DECREASED565 reports
PYREXIA537 reports
PRURITUS528 reports
MALAISE511 reports
DYSPNOEA500 reports
RENAL FAILURE456 reports
PNEUMONIA441 reports
DEATH431 reports
ACUTE KIDNEY INJURY428 reports
ARTHRALGIA413 reports
ERYTHEMA397 reports
DIZZINESS396 reports
CONDITION AGGRAVATED390 reports
ANXIETY386 reports
CONSTIPATION386 reports
ABDOMINAL PAIN378 reports
ANAEMIA373 reports
FALL371 reports
COUGH369 reports
PRODUCT DOSE OMISSION ISSUE361 reports
PRODUCT USE ISSUE354 reports
ASTHENIA345 reports
VOMITING338 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE319 reports
DYSPEPSIA293 reports
SINUSITIS283 reports
PAIN IN EXTREMITY276 reports
DECREASED APPETITE275 reports
URINARY TRACT INFECTION258 reports
DEPRESSION255 reports
BACK PAIN246 reports
INFUSION RELATED REACTION244 reports
COVID 19233 reports
CHRONIC SINUSITIS231 reports
PARAESTHESIA ORAL230 reports
PERIPHERAL SWELLING228 reports
PROCEDURAL PAIN223 reports
COLITIS216 reports
DRY SKIN211 reports
RECTAL HAEMORRHAGE209 reports
DRUG HYPERSENSITIVITY205 reports
HAEMATOCHEZIA202 reports
DERMATITIS ATOPIC198 reports
COLITIS ULCERATIVE196 reports
INFECTION196 reports
INSOMNIA196 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION192 reports
FREQUENT BOWEL MOVEMENTS189 reports
END STAGE RENAL DISEASE186 reports
PSORIASIS186 reports
ORAL CANDIDIASIS185 reports
FEELING ABNORMAL183 reports
WEIGHT INCREASED182 reports
SKIN EXFOLIATION181 reports
EMOTIONAL DISTRESS177 reports
INJECTION SITE PAIN177 reports
RADICULOPATHY177 reports
GAIT DISTURBANCE176 reports
FEMALE GENITAL TRACT FISTULA175 reports
HYPOTENSION175 reports
HYPERTENSION172 reports
VAGINAL DISCHARGE168 reports
PROCTITIS167 reports
MUSCLE SPASMS166 reports
NASOPHARYNGITIS166 reports
VAGINAL FLATULENCE166 reports
EPISTAXIS164 reports
CELLULITIS163 reports
STAPHYLOCOCCAL INFECTION162 reports
NO ADVERSE EVENT161 reports
BLOOD PRESSURE INCREASED160 reports
CHEST PAIN160 reports
ALOPECIA159 reports
ABDOMINAL PAIN UPPER157 reports
ILLNESS156 reports
URTICARIA153 reports
OEDEMA PERIPHERAL150 reports
BRONCHITIS147 reports
GASTROOESOPHAGEAL REFLUX DISEASE144 reports
ABDOMINAL DISCOMFORT143 reports
SEPSIS143 reports
HYPOAESTHESIA141 reports
HOSPITALISATION140 reports
CONTUSION136 reports
DEHYDRATION136 reports
MYALGIA136 reports
SOMNOLENCE135 reports
ASTHMA134 reports
INFLUENZA134 reports

Report Outcomes

Out of 12,998 classified reports for MUPIROCIN CALCIUM:

Serious 57.8%Non-Serious 42.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6,833 (62.7%)
Male4,063 (37.3%)
Unknown7 (0.1%)

Reports by Age

Age 71272 reports
Age 65232 reports
Age 69176 reports
Age 54173 reports
Age 60171 reports
Age 63164 reports
Age 58162 reports
Age 64160 reports
Age 62155 reports
Age 67154 reports
Age 72153 reports
Age 59152 reports
Age 66151 reports
Age 70146 reports
Age 68141 reports
Age 73132 reports
Age 61125 reports
Age 75123 reports
Age 56121 reports
Age 76118 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MUPIROCIN CALCIUM?

This profile reflects 31,213 FDA FAERS reports that mention MUPIROCIN CALCIUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MUPIROCIN CALCIUM?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, NAUSEA, PAIN, PRODUCT USE IN UNAPPROVED INDICATION, MACULAR DEGENERATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MUPIROCIN CALCIUM?

Labeling and FAERS entries often list NORTHSTAR RX LLC in connection with MUPIROCIN CALCIUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.